FDA identified 20 drugs with shortage risks due to coronavirus outbreak

The U.S. Food and Drug Administration has contacted producers of about 20 drugs that either source all of their main ingredients from or are finished in China to gauge if they will face shortages due to the coronavirus outbreak. None of the companies reported that a shortage is expected for their drugs due to the outbreak, an FDA spokeswoman said. "We have been in contact with those firms to understand if they face any drug shortage risks due to the outbreak," FDA spokeswoman Stephanie Caccomo said in a statement late on Monday.